These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28093948)

  • 1. Design and evaluation of a stearylated multicomponent peptide-siRNA nanocomplex for efficient cellular siRNA delivery.
    Wan Y; Moyle PM; Gn PZ; Toth I
    Nanomedicine (Lond); 2017 Feb; 12(4):281-293. PubMed ID: 28093948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional peptide-lipid nanocomplexes for efficient targeted delivery of DNA and siRNA into breast cancer cells.
    Wan Y; Dai W; Nevagi RJ; Toth I; Moyle PM
    Acta Biomater; 2017 Sep; 59():257-268. PubMed ID: 28655658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanosized, peptide-based multicomponent DNA delivery systems: optimization of endosome escape activity.
    Wan Y; Moyle PM; Christie MP; Toth I
    Nanomedicine (Lond); 2016 Apr; 11(8):907-19. PubMed ID: 26979574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable stearylated peptide with internal disulfide bonds for efficient delivery of siRNA in vitro and in vivo.
    Tai Z; Wang X; Tian J; Gao Y; Zhang L; Yao C; Wu X; Zhang W; Zhu Q; Gao S
    Biomacromolecules; 2015 Apr; 16(4):1119-30. PubMed ID: 25686200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a novel nanoparticle by dual modification with the pluripotential cell-penetrating peptide PepFect6 for cellular uptake, endosomal escape, and decondensation of an siRNA core complex.
    Mitsueda A; Shimatani Y; Ito M; Ohgita T; Yamada A; Hama S; Gräslund A; Lindberg S; Langel Ü; Harashima H; Nakase I; Futaki S; Kogure K
    Biopolymers; 2013 Nov; 100(6):698-704. PubMed ID: 23893316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of Cell-Penetrating Peptides with Rod-like Bionanoparticles: Virus-Inspired Gene-Silencing Technology.
    Tian Y; Zhou M; Shi H; Gao S; Xie G; Zhu M; Wu M; Chen J; Niu Z
    Nano Lett; 2018 Sep; 18(9):5453-5460. PubMed ID: 30091612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective small interfering RNA delivery in vitro via a new stearylated cationic peptide.
    Chen B; Pan R; Askhatova D; Chen P
    Int J Nanomedicine; 2015; 10():3303-14. PubMed ID: 25999710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transfection activity of R8-modified nanoparticles and siRNA condensation using pH sensitive stearylated-octahistidine.
    Toriyabe N; Hayashi Y; Harashima H
    Biomaterials; 2013 Jan; 34(4):1337-43. PubMed ID: 23141897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retro-inverso cell-penetrating peptide for siRNA delivery.
    Vaissière A; Aldrian G; Konate K; Lindberg MF; Jourdan C; Telmar A; Seisel Q; Fernandez F; Viguier V; Genevois C; Couillaud F; Boisguerin P; Deshayes S
    J Nanobiotechnology; 2017 Apr; 15(1):34. PubMed ID: 28454579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of a multicomponent peptide-woven nanocomplex for delivery of siRNA.
    Jun E; Kim S; Kim JH; Cha K; So IS; Son HN; Lee BH; Kim K; Kwon IC; Kim SY; Kim IS
    PLoS One; 2015; 10(2):e0118310. PubMed ID: 25705892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of elastin-like polypeptide for targeted specific gene delivery in vivo.
    Yi A; Sim D; Lee YJ; Sarangthem V; Park RW
    J Nanobiotechnology; 2020 Jan; 18(1):15. PubMed ID: 31952530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
    Mo RH; Zaro JL; Shen WC
    Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFP-Based Protein Nanoparticles with Cell-Penetrating Peptide for Efficient siRNA Delivery.
    Guan X; Hu X; Cui F; Li Y; Jing X; Xie Z
    Macromol Biosci; 2015 Nov; 15(11):1484-9. PubMed ID: 26109167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative characterization and cytotoxicity study of TAT-peptide as potential vectors for siRNA and Dicer-substrate siRNA.
    Katas H; Abdul Ghafoor Raja M; Ee LC
    Drug Dev Ind Pharm; 2014 Nov; 40(11):1443-50. PubMed ID: 23962166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-responsive complex in triple negative breast cancer cells.
    Zhang C; Yuan W; Wu Y; Wan X; Gong Y
    Life Sci; 2021 Feb; 266():118886. PubMed ID: 33310044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of siRNA Using Cationic Liposomes Incorporating Stearic Acid-modified Octa-Arginine.
    Yang D; Li Y; Qi Y; Chen Y; Yang X; Li Y; Liu S; Lee RJ
    Anticancer Res; 2016 Jul; 36(7):3271-6. PubMed ID: 27354583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo.
    Hatakeyama H; Ito E; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
    J Control Release; 2009 Oct; 139(2):127-32. PubMed ID: 19540888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrin-releasing peptide receptor-targeted hybrid peptide/phospholipid pDNA/siRNA delivery systems.
    Begum AA; Toth I; Moyle PM
    Nanomedicine (Lond); 2019 May; 14(9):1153-1171. PubMed ID: 31050581
    [No Abstract]   [Full Text] [Related]  

  • 19. Delivery of siRNA Complexed with Palmitoylated α-Peptide/β-Peptoid Cell-Penetrating Peptidomimetics: Membrane Interaction and Structural Characterization of a Lipid-Based Nanocarrier System.
    Jing X; Foged C; Martin-Bertelsen B; Yaghmur A; Knapp KM; Malmsten M; Franzyk H; Nielsen HM
    Mol Pharm; 2016 Jun; 13(6):1739-49. PubMed ID: 26654841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoplasmic delivery of siRNA using human-derived membrane penetration-enhancing peptide.
    Nakamura M; Fujiwara K; Doi N
    J Nanobiotechnology; 2022 Oct; 20(1):458. PubMed ID: 36303212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.